The properties of GABA receptor-mediated responses were examined in noncultured astrocytes, acutely isolated from the mature rat hippocampus.
Whole In contrast, antisera generated against either CX, or p, subunit peptides revealed immunoreactivity predominantly on a subset of processes.
To determine the subcellular distribution of membrane-bound receptors, a fluorescent benzodiazepine derivative was superfused over live astrocytes and visualized with laser-scanning confocal microscopy.
Specific fluorescence was distributed in discrete clusters on the cell soma and a subset of distal processes. Collectively, these data support the view that astrocytes, like neurons, express GABA, receptors and target subunit isoforms to distinct cellular localizations. Astrocytic GABA, receptors may be involved in both [Cl-] Electrophysiological studies indicate that cultured astrocytes and oligodendrocytes express receptors for GABA (reviewed by Blankenfeld and Kettenmann, 1992; Fraser et al., 1994) . The astrocytic GABA, receptor shares many pharmacological properties with the neuronal receptor, including modulation by barbiturates, benzodiazepines, and steroids. GABA, receptor-mediated responses have also been recorded from astrocytes in hippocampal (MacVicar et al., 1989; Steinhauser et al., 1993 Steinhauser et al., , 1994 and retinal (Clark and Mobbs, 1992) slices, oligodendrocytes in corpus callosum slices (Berger et al., 1992) Bergmann glia in cerebellar slices (Mtlller et al., 1994) and stellate glia in the intact pituitary pars intermedia (Mudrick-Donnon et al., 1993) . Although the functional aspects of GABA, receptor activation on astrocytes is not known, further investigations of the physiologic, pharmacologic, and anatomic properties of these receptors may lead to a more clear understanding of their function in the CNS. Recently, a procedure for acute isolation of astrocytes from mature tissue was described Tse et al., 1992) . By using this preparation, not only is the possibility of culture artifact avoided, but agonists can be applied rapidly and uniformly, which is not possible in whole tissue. For example, saturating concentrations of GABA were required to activate glia receptors embedded in tissue slices and, thus, the doseresponse relation and allosteric modulation could not be determined accurately (e.g., Berger et al., 1992; Steinhauser et al., 1993 Steinhauser et al., , 1994 . The first objective of this study was, therefore. to confirm the presence of GABA, receptors on acutely isolated astrocytes and to investigate the electrophysiologic and pharmacologic properties of these receptors using whole-cell patch clamp and rapid perfusion techniques.
In most neurons, activation of GABA, receptors causes an influx of Cl-and a membrane hyperpolarization (Alvarez-Leefmans and Russels, 1990) . In contrast, activation of glial GABA, receptors, in both oligodendrocytes and astrocytes, always leads to an efflux of Cl- (Hoppe and Kettenmann, 1989; MacVicar et al., 1989) . In glia, the nonpassive distribution of Cll is based on the activity of two inwardly directed Cll transporters: an Na+/K+/2Cll cotransporter and a Cl-/HCO-, exchanger (Kettenmann, 1990; Kimelberg, 1990) . Studies have shown that the Cl-equilibrium potential in astrocytes can be as positive as -35 mV, leading to a membrane depolarization of -40 mV following GABA, receptor activation (Kettenmann and Schachner, 1985) . A GABA,-induced membrane depolarization of this magnitude would surpass the activation threshold for voltage-gated Ca*+ channels which have been identified in cultured (MacVicar, 1984; MacVicar and Tse, 1988; Barres et al., 1989) and acutely isolated (Duffy and MacVicar, 1994) astrocytes. It is not known, however, whether GABA,-induced membrane depolarizations cause a change in [Ca"],. It is possible that a GABA,-induced increase in [Ca*+li, which has been reported recently for cultured glial precursor cells (Kirchhoff and Kettenmann, 1992) , could result in activity-dependent modification of astrocytic signaling pathways. The second objective of this study was, therefore, to measure [Ca"], with indo-l fluorometry to determine whether GABA,-induced membrane depolarization evokes Ca*+ influx through voltage-gated Ca2+ channels.
Knowledge of the subcellular distribution of GABA, receptors within single astrocytes is important for determining the functional aspects of receptor expression. For example, GABA, receptors may be targeted and expressed on astrocytic processes, which are in close association with synaptic regions (Peters et al., 1991) . Molecular cloning and low-stringency screening of cDNA libraries have identified at least 1.5 GABA, receptor subunits separated by degree of homology into five families (o(,-~, Blil, yIm3, 6, p; reviewed by Olsen and Tobin, 1990; Burt and Kamatchi, 1991) . Recombinant studies revealed further that subunit combinations differ in sensitivity from agonists and allosteric modulation.
In astrocytes, sequence-and subunit-specific antibodies could reveal the expression of particular subunits and their isoforms which join to construct functional GABA, receptors. The third objective of this study was, therefore, to determine the expression and subcellular distribution of GABAJbenzodiazepine receptors and their subunits using polyclonal antibodies and a novel fluorescent benzodiazepine
derivative. The results demonstrate that GABA, receptors with unique pharmacologic profiles are expressed in mature astrocytes, that GABA, receptor activation depolarizes astrocytes sufficiently to open voltage-gated Ca*+ channels, and that GABA, receptors and subunits are targeted to distinct cellular locations.
This work has been presented in abstract form (Fraser et al., , 1993 .
Materials and Methods
Acute isolation of hippocampal astrocytes. The isolation technique for hippocampal astrocytes has been described previously Tse et al., 1992) . Briefly, transverse hippocampal slices (500 pm) were obtained from Sprague-Dawley rats (2-6 weeks postnatal) and placed in artificial cerebrospinal fluid (aCSF) containing (in mM) 124 NaCl, 5 KCl, 1.3 MgCl,, 2 CaCl,, 26 NaHCO,-, and 10 D-glucose (pH 7.35; 280 mOsm). Slices were transferred to-a magnetic s&ring flask filled with 30 ml of aCSF containing naoain (24-28 U/ml: Sigma. P-4762), the papain activator L-cysteiiex(i mg/lOO U papain'; Siima: C-1276), and 1 mu kynurenic acid (Sigma, . During enzymatic digestion, the solution was stirred continuously and aerated with 95% 0,/5% CO,. Following the 1 hr enzymatic treatment, the slices were washed several times with fresh aCSF and stored at room temperature in aCSE When needed, the CA1 region was dissected free and mechanically triturated with fire-polished Pasteur pipettes in HEPES-buffered DMEM which contained 0.1 mu leupeptin (Sigma, L-2884) and 1 mM kynurenic acid. Isolated cells in suspension were allowed to either settle onto poly-L-lysine-coated coverslips for 20 min or bind securely to poly-L-lysine-coated coverslips by brief centrifugation before the onset of constant superfusion with selected external solutions.
ElectrophysioZogicaZ recording. Patch electrodes were pulled from 1.5 mm o.d. thin-walled glass (TW 150F-4, World Precision Instruments) on a Flaming-Brown micropipette puller (P-87, Sutter Instrument Company). Electrodes had a tip resistance of 4-8 MR when tested in the external solution. The various K+ conductances of the cell membrane (Tse et al., 1992) were suppressed by using an intracellular solution containing (in mM) 130 CsCl. 4 M&l,. 1 CaCl,. 10 HEPES. 10 EGTA, and 2 Mg;+-ATP'(pH 7.2) in combination withan extracellular solution containing (in mu) 119 NaCl, 3 CsCl, 2 MgCl,, 2 CaCl,, 5 BaCl,, 10 D-glucose, and 10 HEPES (pH 7.35). Intracellular Ca*+ concentration was calculated to be -11 nM. In some experiments, NaCl was substituted with equimolar Na+-gluconate to shift the Cl-equilibrium potential. Current recordings were obtained using a single electrode amplifier (Axopatch-IA) in voltage-clamp mode, and filtered (four-pole Bessel) at a low-pass bandwidth of 200 Hz (-3 dB). Analog current waveforms were displayed and digitized simultaneously by PCLAMP software via a Tl-125 A/D interface (Axon Instruments). Liquid junction potentials between electrode and bath solutions were measured and compensated subsequently. All recordings were performed at room temperature (-21°C) and data is reported as the mean ? standard error.
Drug application. Drugs were applied to single cells in the extracellular solution described above by a rapid perfusion system consisting of multiple stainless steel inlet pipes (id. 0.43 mm) secured in a triangular-shaped plexiglass head with one common outlet pipe (i.d. 0.33 mm). The plexiglass head was mounted on a hydraulic manipulator via a 10 cm shaft and positioned within 0.5-1.0 mm of the cell to insure a uniform flow of solution across the entire membrane. Control and drugcontaining solutions were gravity fed from multiple reservoirs (60 ml syringes) through consecutively smaller polyethylene tubing (from id. 1.14 mm to id. 0.58 mm) to the inlet pipes. The tubing containing control solution was split by a "normally open" solenoid valve (Lee Co., LFYA0518232Hj, whereas tubing containing drugs was split by "normallv closed" solenoid valves (Lee Co.. LFVX0500250A).
The cell was 'bathed continuously by a rapidly flowing stream of control solution between drug applications. Rapid solution changes were achieved by simultaneously closing the control valve and opening a drug valve. Each valve was controlled by a solenoid driver coupled to a TTL-pulse from the A/D interface.
Fborometric measurement of intracellular Ca2+. Intracellular Ca*+ ([Ca*+],) changes were monitored by measuring indo-l fluorescence. Astrocytes were loaded with dye by adding 50 pg indo-l/AM (Molecular Probes, I-1203; sonicated with 10 p,l DMSO and 10% pluronic acid) to the trituration media. The period during which the cells were initially dissociated and allowed to settle was sufficient for dye loading. Once adhered to the cover slip, astrocytes were superfused with aCSE Single astrocytes were illuminated at 380 nm and the fluorescence outputs at 405 and 485 nm were measured simultaneously using a dichroic mirror and two photomultiplier tubes (PMT, Hamamatsu, C1053-01). Illumination frequency (l-2 Hz) and duration (50 msec) were controlled by an electronic shutter (UniBlitz). PMT current output was converted to voltage and digitized at 200 Hz using a Tl-125 A/D interface and AXOTAPE software (Axon Instruments). Following each experiment, autofluorescence was determined by superfusion of 1 mM MnZ+ in the presence of the nonfluorescent Ca 2+ ionophore 4-bromo A-23187 (1 PM; Molecular Probes, B-1494). Intracellular Ca*+ concentration was estimated by the equation from Grynkiewicz et al. (1985) :
where K, is 250 nm, R,,, is 0.2, R,,, is 3.0, and S/S, was 10.667. All values except for Kd were determined experimentally on our recording setup using calibrated Ca2+ solutions. Drugs were applied by changing the superfusion in the bath. The perfusion rate was approximately 1.0 ml/min, which allowed a complete solution change in the bath (volume 150 pl) in <30 sec.
Antibody production. A polyclonal antibody which recognizes the GABAJbenzodiazepine receptor complex was generated against the affinity-purified GABA, receptor. Purification of the protein was carried out on a benzodiazepine affinity column according to Sigel et al. (1982) . One hundred to three hundred micrograms of the purified receptor was injected into the lymph nodes of New Zealand White rabbits.
Subunit-specific antibodies were generated in New Zealand White rabbits immunized with peptides corresponding to the N and C termini of the ~1, and p, subunits. The following subunit-specific sequences were (Y, N-terminus,
Peptides were coupled to rabbit serum albumin (RSA) with glutaraldehyde (Chow et al., 1984) and by reacting the C-terminal cysteine residue with succinimidyl-phenyl-maleimide (Gitman et al., 1985) . Rabbits were injected at multiple intradermal sites with 1 mg of the conjugated peptide in the RIB1 adjuvant system (RIB1 Immunochem., Hamilton, MN).
For all antibodies, booster injections were performed every 2-3 weeks. The animals were exsanguinated after 10 weeks of the initial immunization. Immunoglobulin fractions (IgG) were precipitated in saturated ammonium sulfate, dialyzed against phosphate buffer, and stored at -20°C. IgG fractions were assayed for recognition of the GABA, receptor by dot blots and Western blotting of affinity-purified GABA,/ benzodiazepine receptors and crude glycoproteins from rat brain.
Western blot analysis. Purified GABA, receptors or crude glycoproteins were electrophoresed on 4-15% or 7.5% linear gradient polyacrylamide SDS gels, respectively, according to the method of Laemmli (1970) . Gels were silver stained or electrophoretically transferred to nitrocellulose by the method of Towbin et al. (1979) . Nitrocellulose membranes containing the transferred proteins were blocked with 5% nonfat dry milk in TBST [lo mM Tris-HCl, pH 8.0,0.15 M NaCl, 0.02% Tween-20 (Sigma, P-1379)] and incubated with several dilutions of the antibodies in the same buffer at 4°C overnight. Blots were then washed three times with fresh TBST and incubated with alkaline phosphatase conjugated to goat-anti-rabbit IgG (Promega) for 2 hr at room temperature. The blots were washed twice in TBST, rinsed with water, and developed with p-nitrotetrazolium blue chloride (0.1 mg/ml; Sigma) and 5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt (0.005 mg/ml; Pierce).
Glycoprotein fractions used for immunoblotting were obtained from rat brain by chromatography on a wheat germ agglutinin Sepharose-4B column @GA-Sepharose-4B).
Briefly, rat brain-was homogenized in 10 mM Tris-HCl (uH 7.4) with 300 mu sucrose. This homogenate was centrifuged at 1060 X g for 12 min, and the supernatant ientrifuged again at 27,000 X g for 35 min. The pellet obtained was resuspended and homogenized in the same buffer without sucrose, and centrifuged as before. The final pellet was homogenized in 10 mM Tris-HCl (pH 7.4), 2.5% Triton X-100, and 150 mM KCl, shaken for 30 min, and centrifuged at 100,000 X g for 60 min. The supernatant obtained contained the solubilized proteins that were applied to a WGA-Sepharose 4B chromatography column. Glycoproteins were eluted from the column with 25 mM N-acetylglucosamine. Fractions were assayed by SHflunitrazepam binding to determine fractions that contained the GABA,/ benzodiazepine receptor. Nonspecific binding was measured in the presence of 300 nM clonazepam. 3H radioactivity was counted in Scintiverse on a Beckman LS-1801 Scintillation Counter. In all steps, a cocktail of protease inhibitors (Sigma) was used, which contained iodoacetamide (I miw), o-phenanthroline (1 mM), leupeptin (1 mM), aprotinin (1 mM), and pepstatin (0.5 mglml).
fmmunocytochemistry. Isolated cells, adhered securely to coverslips, were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) for 10 min at room temperature. Membranes were permeabilized with 95% EtOH/5% acetic acid for 10 min at -10°C. A mouse monoclonal antibody directed against glial fibrillary acidic protein (MAb-GFAP, 1: 100; Boehringer Mannheim) and one of the rabbit polyclonal antibodies generated against the GABA,/benzodiazepine receptor (PAb-967, 1: l OO-250), an CK, subunit peptide (PAb-B, 1: loo), or a p, subunit peptide (PAb-Q, 1:lOO) were applied together in PBS containing 10% normal goat serum, 3% bovine serum albumin, and 0.05% Tween-20 for 2 hr at 37°C. Antigen/antibody complexes were visualized by incubation of coverslips in fluorescein-conjugated goat antibody to mouse IgG (1: 100; Jackson) and rhodamine-conjugated goat antibody to rabbit IgG (1:lOO; Jackson). All steps were separated by five 10 min washes in PBS containing 0.05% Tween-20. Coverslips were then mounted with Fluorosave (Calbiochem Inc.) on glass slides and viewed with a Nikon microscope equipped with appropriate filter sets. Images were scanned in RGB (1000 dpi; Leafscan 35) from Kodachrome color film, converted to a black/white scale, and final output produced by a Linotronic printer. Controls at the immunohistochemical level included omission of primary antibodies or replacement of polyclonal antibodies with preimmune sera.
Fluorometric mapping of GABA/benzodiazepine receptors. A fluerescent benzodiazepine derivative was prepared by alkylation of the amide on Ro 7-1986 by BODIPY alkyl halide. This compound maintains high affinity and specificity for central benzodiazepine receptors and has been characterized previously by mass spectrometry, equilibrium binding to brain membranes, and fluorescence microscopy (Velazquez et al., 1989; McCabe et al., 1990) . Astrocytes, adhered securely to coverslips, were placed in the perfusion chamber on an upright laserscanning confocal microscope (Meridian Instr., Inc.). Once an astrocyte had been identified visually by its distinct morphology, the chamber was perfused with 5 nM of the BODIPY-Ro 7-1986 derivative in phosphate-buffered saline (PBS) for 20 min. Total binding was determined following a 2 min wash with PBS. Nonspecific binding was determined as above, with the exception that the derivative was coperfused with 500 nM diazepam. All binding experiments were performed at reduced temperatures (<8"C) to suppress endocytosis of the derivative. Fluorescent images from cells were obtained with a silicon-intensified target camera (SIT, Hamamatsu, C2400) through a 40X, 0.75 numerical aperture, water-immersion objective (Zeiss). Video frames were averaged and digitized into a 512 X 480 pixel array by an eight-bit A/D board of an image processor (Series 15 1; Imaging Technology Inc.) controlled by a personal computer (Packard-Bell 386). Digital images were enhanced by thresholding and histogram stretching; pixel intensities were determined by averaging. At the completion of the binding experiments, a subset of cells was fixed and stained for GFAP to verify its astrocytic phenotype.
Results

Identijcation
and characteristics of astrocytes Acutely isolated astrocytes from the hippocampal CA1 region are known to be immunoreactive for GFAP Tse et al., 1992) , the predominant protein of intermediate filaments in astroglia. They were identified visually by distinct morphological features, including a small soma diameter (-8 pm) and bushy processes with random orientation. In contrast, pyramidal neurons and interneurons were easily recognized by their larger smooth cell bodies and l-3 tapering dendrites (e.g., Kay and Wong, 1986; Fraser and MacVicar, 1991) . Neurons isolated simultaneously do not stain for GFAP (Tse et al., 1992) . Identification of cell type can also be inferred by membrane current patterns evoked by voltage steps or capacitance measurements obtained via a calibrated potentiometer. In astrocytes, inward Na+ currents were not observed under whole-cell voltage clamp ( Fig. 1) and action potentials could not be generated in the current-clamp mode (data not shown). In contrast, neurons coisolated with astrocytes exhibited robust inward transient and sustained currents carried by Na+ and Ca*+/Ba*+, respectively (Fig. 1) . Typically, the larger astrocytic surface area was reflected by large capacitance values (61 + 3 pF, range 25-100 pF, II = 65/77; 12 cells could not be estimated because of values > 100 pF), whereas neurons had smaller values (12 t 1 pE range 4-21 pE IZ = 32).
GABA-activated membrane currents
In all pyramidal neurons (n = 32) and 91% of astrocytes (n = 77/85), application of GABA activated an inward current when the membrane potential was voltage clamped at -80 mV (Fig.  1) . At a GABA concentration of 50 pM, the peak inward current amplitude in pyramidal neurons and astrocytes was 1562 2 146 pA (range 791-2500 pA, n = 14) and 486 ? 38 pA (range 38-2000 pA, n = 50), respectively. In both cell types, the current activated quickly, followed by marked desensitization.
The peak amplitudes of both neuronal and astrocytic GABAactivated currents were concentration dependent. To reveal the dose-response relation for both cell types, variable concentrations of GABA (1, 3, 10, 30, 100, 300, 1000 FM) were applied for 3 set at 5 min intervals (Fig. 2) . This delay was sufficient for full recovery from desensitization. The peak amplitude of GABA responses was plotted as a function of GABA concentration, normalized to a saturating response elicited by 1 mM GABA. pA, n = 9) and 1064 t 167 pA for astrocytes (range 275-2050 pA, n = 12). Responses significantly above the noise level could be elicited with l-3 FM GABA and the current amplitude increased in a sigmoidal fashion with the GABA concentration (Fig. 2C) . The dose-response relations were in agreement with the conventional expression
where I is the amplitude of the GABA-activated current, EC,, is the GABA concentration which evokes the half-maximal response, and IZ is the Hill coefficient. The EC,, and hill coefficient values for neurons were 14 FM and 1.1, whereas astrocytes had values of 50 pM and 1.6. The maximal current amplitudes and EC,, values suggested that GABA acting at neuronal receptors had greater potency and efficacy. The hill coefficient values suggested that the astrocytic receptors must bind a minimum of two GABA molecules to open the receptorlionophore, whereas the receptors on pyramidal neurons have only one binding site or slight allosteric interaction between two putative sites (Bormann and Clapham, 1985) .
Reversal potential of the GABA-activated current The ionic species permeating the astrocytic GABA receptor/ionophore was identified by analyzing the reversal potential of the GABA-induced current (Fig. 3) . Two strategies were employed to vary the membrane potential. First, the membrane potential or 100 pM GABAto an astrocyte re;ealed inward &rents of increasing amplitude from a holding potential of -80 mV. These concentrations represent the linear portion of the concentration-response curve. The whole-cell capacitance was 52 pE C, The dose-response relation for the neuronal and astrocytic GABA-evoked inward current, in which the peak current at variable concentrations was normalized to the maximal response obtained with 1 mu GABA. Each point represents the mean + SEM from three cells.
was altered to steady-state levels of -80, -60, -40, -20, 0, 20, 40 , and 60 mV for several seconds followed by a rapid application of GABA ( Fig. 3A ; IZ = 4). The current induced by 50 FM GABA reversed in polarity close to 0 mV. Second, the membrane potential was ramped from -100 to 100 mV over 4 set (Fig. 3B) . To resolve the GABA-activated current, the rampinduced current in standard bathing solution was subtracted from that obtained in the presence of 50 pM GABA (Fig. 3C ). The GABA current reversed at 1.0 ? 1.8 mV (range -3-7 mV, IZ = 5). These values coincided with the expected Cl-equilibrium potential (E,, = 0 mV) as derived by the Nernst equation. Moreover, decreasing the [Cl-], concentration to 90 and 55 mM, by substitution with the nonpermeable anion gluconate, shifted the reversal potential to 12.6 2 0.8 (range 11-14 mV, IZ = 3) and 22.3 + 1.5 (range 20-25 mV, n = 3) mV, respectively (Fig.  30) . These values are in close agreement with the calculated Cl-equilibrium potentials of 11 and 24 mV. These data indicate that GABA activates a Cl-conductance in acutely isolated astrocytes, indicating the expression of GABA, receptors.
Pharmacological properties of the GABA response The GABA-activated current recorded from acutely isolated astrocytes was characterized further by testing drugs affecting GA-BAA-mediated responses as described in other cells. To ensure a stable response, several GABA-activated currents were monitored before and after application of a particular drug. Consec-in Astrocytes utive tests were separated by 5 min. The GABA, receptor agonist muscimol (50 pM) mimicked the GABA-induced response (Fig. 4A) . The amplitude of the muscimol response, however, was enhanced with respect to GABA by 45 ? 15% (range 6-93%, n = 5). Coapplication of GABA and 10 FM of the GABA, receptor antagonist bicuculline or 10 pM of the Cl-channel blocker picrotoxin depressed the GABA responses by 79 + 15% (range 48-96%, IZ = 3) or 74 + 11% (range 52-86%, n = 3), respectively (Fig. 4B,C) . Depression of the GABA-induced current was reversible upon washout of the antagonists. This set of experiments indicates that the GABA-induced inward current is caused by the activation of GABA, receptors.
The pharmacological properties of the astrocytic GABA, receptor were characterized by testing the effect of GABA, receptor modulators, namely the barbiturate pentobarbital, the benzodiazepine diazepam and the benzodiazepine inverse agonist DMCM. Similar to neurons, sodium pentobarbital (25 pM; Fig.  5A ) and diazepam (10 PM; Fig. 5B ) potently and reversibly enhanced the astrocytic GABA-activated current by 159 ? 51% (range 42-315%, n = 5) and 56 + 14% (range 18-260%, n = 17), respectively. Surprisingly, DMCM either potentiated (15 + 4%, range 7-25%, IZ = 3/15; Fig. 5C ) or depressed (19 & 3%, range 8-40%, n = 12/15; Fig. 5D ) the astrocytic GABA-activated current, indicating heterogeneity with respect to receptor expression. In contrast, GABA-activated currents recorded in Figure 4 . Pharmacological characteristics of the astrocytic GABA current suggest a GABA, receptor. A, Rapid application of 50 PM GABA evoked control currents that were similar to those evoked by 50 FM muscimol, a specific GABA, receptor agonist. The inward current evoked by an equivalent concentration of muscimol, however, was typically larger in amplitude. The whole-cell capacitance was 100 pE B, Inward currents were evoked by rapid application of 50 FM GABA and could be reversibly depressed by coapplication the GABA, receptor antagonist bicuculline (10 PM). The whole-cell capacitance was 98 pE C, Inward currents were evoked by rapid application of 50 FM GABA and could be reversibly depressed by coapplication the Cl-channel blocker picrotoxin (10 FM). The whole-cell capacitance was 55 pE pyramidal neurons were depressed consistently by coapplication of DMCM (44 ? 5%, range 33-56%, n = 7; Fig. 5E ). These experiments suggest that astrocytic GABA receptors share similarities with, but are not identical to, neuronal GABA, receptors.
GABA-induced
Ca2+ responses GABA-induced changes of intracellular Ca*+ were analyzed in acutely isolated astrocytes using the AM form of indo-l and standard fluorometric techniques. Bath superfusion of GABA (1 mM) caused a transient increase in [CaZ+] , in 30% of the astrocytes tested (n = 11/33; Fig. 6 ). At rest, the ratio (R) of the fluorescence intensities at two wavelengths (405 nml485 nm) was 0.37 ? 0.04 (n = 11). Application of GABA increased the ratio to 0.41 + 0.5 (n = 11). These values corresponded to an average increase in [Ca*+], from 172 nM in control to 296 nM in the presence of GABA. Increasing external K+ from control levels of 5 mM to 50 mu also increased [Ca"], by opening verapamil-sensitive voltage-activated Ca2+ channels ( Fig. 6A ; Duffy and MacVicar, 1994) . To investigate the possibility that GABA also increased [CaZ+] , by influx through voltage-activated Ca2+ channels secondary to a GABA,-induced membrane depolarization, the sensitivity of GABA-evoked [CaZ+] , changes to verapamil and picrotoxin was examined. The Ca*+ channel blocker verapamil (150 pM) reversibly depressed the GABAinduced increase in [Ca*+], (n = 2; Fig. 6B ). Verapamil did not have an inhibitory effect, however, on the magnitude of the whole-cell GABA-activated current (data not shown; n = 5). Picrotoxin (100 FM), which specifically blocks Cl-channels, The whole-cell capacitance was 72 pE A2, Control currents elicited by 50 PM GABA could be reversibly potentiated by coapplication of 10 FM diazepam, a benzodiazepine receptor modulator. The whole-cell capacitance was 65 pE A3, In a subpopulation of astrocytes (20%), inward currents evoked by 50 FM GABA could be reversibly enhanced by coapplication of 10 FM DMCM, a benzodiazepine inverse agonist. The whole-cell capacitance was 65 pE A4, In the remainder of astrocytes (80%), coapplication of 10 pM DMCM resulted in a depression of the GABA-activated current. The whole-cell capacitance was 56 pE B, For comparison, reversible depression of a neuronal (CA1 pyramidal) inward current by DMCM is illustrated. The whole-cell capacitance was 16 pE C, A summary of the benzodiazepine actions on GABA-activated currents from acutely isolated astrocytes (astro) and CA1 pyramidal neurons (neurons).
reversibly depressed the GABA-induced increase in [Ca*+], (n = 2; Fig. 6C ).
Antibodies and Western blotting
Several antibodies were prepared that specifically recognized the GABA, receptor complex and its subunits at the immunoblot and immunocytochemical level (Gu et al., 1992 (Gu et al., , 1993 PerezVelazquez and Angelides, 1993) . Antibody 967 (PAb-967), generated against the affinity-purified GABA,/benzodiazepine receptor of rat brain, recognized two closely spaced immunoreactive bands in the 52-56 kDa molecular mass range (Fig. 7A, lane 2) . These bands corresponded to the predicted molecular mass for the population of GABA, receptor subunits (LX, (48) (49) (50) (51) (52) (53) p, (55) (56) (57) and the migration of these subunits in this 4-15% linear polyacrylamide gradient gel system. The immunodetection of the GABA, receptor subunits is specific since preimmune IgG from the same rabbit, 967, (Fig. 7A,  lane 1 Peptides corresponding to several regions of the GABA, receptor were synthesized as antigens in order to prepare sequence-and subunit-specific antibodies. Of the four that were injected, only two of the anti-peptide antibodies were positive in dot blots and Western blotting. These anti-peptide antibodies, generated against the (Y, subunit C-terminus (PAb-B) and p, subunit N-terminus (PAb-Q) of the GABA, receptor, recognized polypeptides at apparent molecular masses of 50 kDa (Fig. 7B , lane 2, C, lane 3) and 55 kDa (Fig. 7B, lane 4, C, lane 5) , respectively. These molecular masses corresponded precisely to those predicted from the amino acid sequence encoded in the cDNA of these subunits in rat brain. preimmune IgG from each of the antibodies used (Fig. 7B , lanes 1, 3; C, lanes 2, 4). Further studies with the anti-peptide antibodies showed that, while they were not able to immunoprecipitate GABA, receptors from solubilized rat brain membranes, immunoblot and immunocytochemical analysis of both (Y,-and p,-transfected cells showed specific and high-affinity staining (Perez- . It is unlikely that PAb-B recognized additional cx subunit isoforms (e.g., (Y*& since the peptide sequence was entirely specific for the (Y, variant. It is possible that PAb-Q may have cross-reacted with the l3, and p3 variants, considering the degree of homology between the N-termini of the p subunits ), although we have no evidence for such cross-reactivity.
Immunocytochemical evidence for GABA, receptor expression The expression and localization of GABA, receptors was determined by dual labeling acutely isolated astrocytes with a monoclonal antibody against GFAP (MAb-GFAP) and one of three polyclonal antibodies which recognize the GABAJbenzodiazepine receptor (PAb-967), an IX, subunit peptide (PAb-B), or a p, subunit peptide (PAb-Q). PAb-967, which recognizes multiple GABA, subunit isoforms, localized immunoreactivity on the astrocytic cell body and most large processes (Fig. 8A) . In contrast, antibodies generated against either an (Y, subunit peptide (PAb-B; Fig. 8B ) or a l3, subunit peptide (PAb-Q; Fig. 8C ) localized immunoreactivity predominantly on a distinct subset of processes. Pyramidal and fusiform neurons coisolated with astrocytes displayed intense labeling along the plasma membrane of both the soma and proximal dendrites (data not shown). The intensity of fluorescence was considerably greater for neurons than astrocytes. Control experiments in which the cells were incubated with preimmune sera did not display immunoreactivity (Fig.  80 ). In addition, the immunoreactive product on astrocytes was similar whether the MAb-GFAP was present or omitted, suggesting that cross-reactivity between primary antibodies did not underlay the staining patterns.
Benzodiazepine binding on live astrocytes The distribution of central GABA,/benzodiazepine receptors on live astrocytes was determined by applying 5 nM of the fluorescent benzodiazepine derivative Ro 7-1986-BODIPY (Velazquez et al., 1989; McCabe et al., 1990) . Total binding, revealed by laser-scanning confocal microscopy, was distributed in discrete clusters on both the cell body and a subset of processes (n = 1 l/l 1; Fig. 9B ). Competitive displacement of specific binding by coperfusion of 500 nM diazepam revealed nonspecific binding (Fig. SC) . The average pixel intensity decreased by 77 ? 3% (range 64-88%, n = 11). In agreement with previous findings, specific binding on neurons was greatest on the soma with the fluorescence intensity tapering toward distal dendrites (data not shown; Velazquez et al., 1989) . The pixel intensity on neurons was typically twofold greater than astrocytes, indicating higher benzodiazepine receptor density. Control experiments with either plasma membrane (DiI, IZ = 3; Nile red, IZ = 2) or lectin (concanavalin-A-tetramethylrhodamine; II = 3) markers revealed homogeneous fluorescence across the entire astrocytic membrane, indicating that fluorescent benzodiazepine hot spots were not due to excessive membrane folding or glycoprotein aggregation, respectively (data not shown; Velazquez et al., 1989) . At the completion of experiments, a subpopulation of cells was fixed and immunostained for GFAP to verify its astrocytic phenotype (n = 515; Fig. 9D ).
Discussion
The results of this study demonstrate that noncultured astrocytes from the mature rat hippocampus express abundant GABA, receptors. Analysis of benzodiazepine pharmacology indicates that astrocytic GABA, receptors are both heterogeneous among the astrocyte population and distinct from neuronal receptors. Activation of GABA, receptors in astrocytes results in an efflux of Cl-which can significantly depolarize these cells to a potential at which voltage-gated Ca*+ channels open. Moreover, the data show that astrocytes, like neurons, target GABA, receptors and subunits to distinct cellular locations.
Electrophysiology
The GABA-activated Cl-channel in cultured astrocytes has been shown to be similar to the neuronal GABA, channel (Blankenfeld and Kettenmann, 1992; Fraser et al., 1994) . The present work indicates that acutely isolated astrocytes also have a GABA receptor coupled to a Cl-channel. The GABA-activated Cl-current was depressed by the GABA, receptor antagonist bicuculline and mimicked by muscimol, a selective GABA, receptor agonist. Moreover, the current had a reversal potential close to the Cl-equilibrium potential and was depressed by the Cll channel blocker picrotoxin.
The astrocytic current evoked with a saturating concentration of GABA (1 mM) was one-half the amplitude of the current recorded under identical conditions in neurons. The whole-cell capacitance of astrocytes was typically fivefold larger than neurons, suggesting that average receptor density on neurons is considerably greater than on astrocytes. Nonetheless, GABA, receptor activation on astrocytes in vivo could evoke a substantial Cll efflux and localized membrane depolarization, since it is likely that the true current amplitude was underestimated. For example, the complex morphology of astrocytes and uneven distribution of receptors along the membrane undoubtedly compromised space-clamp control. In addition, enzymatic treatment with papain has been reported to abolish inhibitory postsynaptic potentials, suggesting proteolytic digestion of the receptor/channel complex (McCarren and Alger, 1987) .
Recombinant studies have revealed that (Y subunit expression controls GABA receptor sensitivity (Levitan et al., 1988) . Doseresponse analysis of acutely isolated cells demonstrated that the ED,, was different between CA1 pyramidal neurons and astrocytes. The ED,, for pyramidal neurons (14 pM) was similar to recombinant receptors containing the (Y, subunit, whereas the ED,, for astrocytes (50 FM) is compatible with 01~ expression (Levitan et al., 1988) . Caution must be exercised in interpretation of these results, however, since the whole-cell current is probably derived from multiple subunit combinations. Indeed, (Y, immunoreactivity on astrocytic processes was demonstrated in this study.
Functional expression of cloned subunits in combination with electrophysiological assays has demonstrated that the c@ subunit combination is sufficient for modulation by barbiturates (Schofield et al., 1987) . Benzodiazepine modulation, however, requires the addition of a third subunit from the y subfamily . In acutely isolated astrocytes, the GABA-activated inward current was modulated by barbiturate and benzodiazepine receptor ligands. Pentobarbital and diazepam potentiated the GABA-induced whole-cell current. These data are consistent with previous reports for cultured astrocytes (Bormann and Kettenmann, 1988; Rosewater and Sontheimer, 1994) , cultured oligodendrocytes (Blankenfeld et al., 1991) , and both cultured and acutely isolated neurons (e.g., Ransom and Barker, 1976; Kaneda et al., 1989; Twyman et al., 1989; Yakushiji et al., 1989) . Both compounds increase the mean channel open time: barbiturates by increasing open duration and diazepam by increasing the frequency of opening (Twyman et al., 1989) .
The benzodiazepine inverse agonist DMCM is known to depress the GABA-activated current in oligodendrocytes (Blankenfeld et al., 1991) , neurons Puia et al., 1989; Bovolin et al., 1992) , chromaffin cells (Bormann and Kettenmann, 1988) , and a subpopulation of cultured astrocytes obtained from spinal cord ("fibrous";
Rosewater and Sontheimer, 1993). The compound decreased channel opening frequency, without altering conductance or opening duration (Vicini et al., 1987) . In contrast, DMCM enhances the GABA-activated current in cultured astrocytes obtained from cortex (Backus et al., 1988; Bormann and Kettenmann, 1988) , cerebellum (Bovolin et al., 1992) , and spinal cord ("protoplasmic"; Rosewater and Sontheimer, 1993) . Indeed, cultured astrocytes from cerebellum express high levels of the y, subunit (Bovolin et al., 1992) which has been associated with DMCM enhancement of GABA-activated currents in recombinant studies (Puia et al., 1991) . In 20% of acutely isolated astrocytes, DMCM also enhanced the GABAactivated current, suggesting that these GABA, receptors express similar subunit combinations. In the remaining 80% of astrocytes DMCM depressed the GABA responses, suggesting that an alternative y subunit isoform was expressed. Interestingly, the DMCM-induced depression in astrocytes was less than one-half the depression observed in pyramidal neurons. The differential benzodiazepine pharmacology suggests subunit heterogeneity between not only astrocytes and neurons, but also within the astrocytic population.
GABA-activated Caz+ influx
The increase in [Ca2+li induced by GABA could potentially occur through two mechanisms: influx through voltage-gated Ca2+ channels (MacVicar, 1984) and/or release from intracellular stores (Nilsson et al., 1993) . Our finding that the GABA-activated increase in [Ca*+], was inhibited in the presence of either the Ca*+ channel blocker verapamil or the Cllchannel blocker picrotoxin points to the former explanation. Verapamil did not diminish the GABA-activated current recorded in whole-cell mode; moreover, the presence of verapamil-sensitive Ca*+ channels has been demonstrated previously (Duffy and MacVicar, Figure 8 . Digital micrographs of acutely isolated hippocampal astrocytes illustrating dual labeling for glial fibrillary acidic protein (MAb-GFAP) and either GABAJbenzodiazepine receptors (GABA,) or individual subunit peptides (a, or p,). A, GFAP-positive astrocytes react with antisera 1994). The Ca*+ influx, therefore, was mediated by GABA,-induced membrane depolarization. The indo-1 experiments provide clues as to the magnitude and polarity of the membrane potential response to GABA. This could not be determined under whole-cell voltage clamp since the cell interior is dialyzed and the Cl-gradient artificially distorted. The threshold for activating Ca2+ influx in acutely isolated astrocytes is reached when external K+ is increased to 20 mM corresponding to a depolarization of approximately -45 mV (Duffy and MacVicar, 1994) . These data indicate that GABA must depolarize the cell membrane to at least this potential, supporting previous studies suggesting that the Cl-reversal potential in astrocytes is positive to resting potential (Kimelberg and Frangakis, 198.5; Kettenmann et al., 1987) .
Astrocytes in vivo are coupled extensively by gap junctions (Ransom and Carlini, 1986) and maintain a significant K+ permeability at the resting membrane potential (Walz, 1989) . Whether local depolarization by GABA could attain the activation threshold for Ca*+ channel opening in vivo is speculative, but may occur under certain conditions. For example, a constriction in the diameter of a process and clustering of the GABA, receptorlionophore in close association with Ca2+ channels would facilitate local depolarization and Ca2+ channel activation. Furthermore, conditions which alter membrane and gap junction resistance (e.g., neurotransmitter modulation) could facilitate this event.
Subcellular localization of GABA, receptors
Until recently, immunocytochemical studies have generally failed to identify GABA, receptor expression in astrocytes (reviewed by Fraser et al., 1994) . This lack of evidence may be due to lower levels of receptor expression making detection in tissue sections difficult. Indeed, the absolute amount of GABA, subunit mRNA expressed by astrocytes was two orders of magnitude less than neurons when quantified by competitive polymerase chain reaction (Bovolin et al., 1992) . A lower expression of receptors is also consistent with our electrophysiological and anatomical assays. The antibody staining reported here is probably due to the increased resolution available with isolated cells in combination with the antigens chosen for antibody production (Gu et al., 1992 (Gu et al., , 1993 Perez-Velazquez and Angelides, 1993) . Our data suggests that at least some astrocytic receptors may include the ct, p, subunit combination, together with an unknown isoform of the y subunit.
The specificity of the antibody staining in this study can be inferred by several observations: (1) purified receptors or subunit-specific peptide sequences were used as antigens; (2) selective recognition of subunit(s) from either crude glycoproteins or purified GABA, receptors on Western blots; (3) good correlation between immunoreactive patterns and fluorescence binding assays; (4) good correlation between neuronal staining and previously reported patterns; and (5) lack of staining with preimmune sera. The immunoreactive patterns observed within hippocampal astrocytes suggests single-cell heterogeneity. Polyclonal antibody 967, which recognizes several subunits and possibly their isoforms, localized receptors to the cell body and a subset of processes. Cytoplasmic staining was observed, in agreement with previous immunocytochemical studies on astrocytes (Gu et al., 1993; Rosier et al., 1993) , which may reflect receptor transport and/or turnover (Somogyi et al., 1989; Zimprich et al., 1991; Thompson et al., 1992) . Polyclonal antibodies generated against either (Y, or p, subunit peptides revealed localization predominantly on astrocytic processes. Taken together, these data suggest GABA, subunits may be distributed differentially within single astrocytes. Perhaps the (Ye subunit, whose expression is suggested by our electrophysiological data, may be localized on the cell body which is typically devoid of CX, subunit immunoreactivity. The GABA, receptors on the cell body may contain a p subunit other that the p, isoform (e.g., &), since PAb-967 and PAb-Q have been reported previously to recognize different subunits (Gu et al., 1993) , or, alternatively, simply may not contain a p subunit (Fritschy et al., 1992) . Interestingly, a monoclonal antibody generated against a similar portion of the p, subunit N-terminus resulted in similar staining of cerebral astrocytes that was distinct from the pz and p3 isoform distribution (Rosier et al., 1993) . A nonrandom distribution of subunits has been reported recently for neurons (Fritschy et al., 1992) . Given the number of subunits identified, many combinations are possible which form a functional receptor. Recent evidence, however, would suggest that subunits assemble into preferred combinations (Angelloti et al., 1993) . In fact, a single subunit combination may predominate in a particular cell (Fritschy et al., 1992) and subunit assembly may then determine cellular sorting (Perez-Velaquez and Angelides, 1993) . In astrocytes, the 01, and p, subunits may colocalize in a single receptor and thereby be targeted to distinct processes.
The benzodiazepine Ro 7-1986, which has high affinity and selectivity for central GABA, receptors (Gavish and Snyder, 1981) , has been used previously for fluorescent ligand binding assays on membrane fractions and live cells (Valequez et al., 1989; McCabe et al., 1990) . On live astrocytes, membranebound receptors were segregated into discrete patches on the cell body and distal processes. This observation is consistent with the immunoreactive findings and supported by previous studies on cultured astrocytes indicating an uneven distribution of GA-BA, receptors along the plasma membrane (Bormann and Kettenmann, 1988; Ventimiglia et al., 1990) . GABA, receptors clustered on astrocytic processes may be in close proximity to inhibitory synapses, as has been recently demonstrated for Bergmann glial cells (Miiller et al., 1994) . Surprisingly, a high density of receptors are localized on the cell body. These receptors may be activated by neuronally released GABA, flowing out of the synaptic cleft, or alternatively by GABA release from adjacent astrocytes (Sarthy, 1985) . raised against GABA, receptors affinity purified on a benzodiazepine column . Note the punctate staining on the cell body (double arrow) and on numerous larger processes (single arrow). B, GFAP-positive astrocytes react with antisera generated against the cq subunit C-terminal peptide (PAb-B). Note that the staining is pronounced in a select subset of processes (single arrow). The cell body, marked by the double arrow, had weak levels of immunoreactivity. C, GFAP-positive astrocytes react with antisera generated against the p, subunit N-terminal peptide (PAb-Q). Note that the staining is pronounced in a select subset of processes (single arrow). The cell body, marked by the double arrow, was devoid of immunoreactivity. D, Staining was not observed on GFAP-positive astrocytes following substitution of the PAbs with their respective preimmune sera. In this example, PAb-967 was substituted with preimmune from rabbit-967. 
